Welcome to our dedicated page for Identa Rvice news (Ticker: IDTA), a resource for investors and traders seeking the latest updates and insights on Identa Rvice stock.
IDenta Corp. (IDTA) develops and supplies rapid field detection, home diagnostic testing, and forensic identification products for narcotics, drugs, explosives, homeland security, law enforcement, and consumer markets. Company news centers on periodic financial results, profitability, cash position, working capital, inventory, customer activity, and product delivery for government agencies, law enforcement organizations, distributors, and other global customers.
Recurring updates also cover market expansion, distributor relationships, operational efficiency, product development, and shareholder meeting or governance matters tied to the company's public-company structure.
IDenta Corp. (OTCQB: IDTA) has launched a unique patent kit on Amazon capable of identifying 30 types of illicit drugs with a single test, marking it as the first of its kind globally. The CEO, Amichai Glattstein, highlighted the rarity of launching a patented product on Amazon, emphasizing the significant market potential in Home Diagnostics and Drug Detection Solutions. This innovative product aims to position IDenta as a major player in the online retail market for drug detection.
IDenta Corp. (OTCQB: IDTA) has introduced a new online sales channel under the Touch&Know brand, offering home drug detection kits. This launch capitalizes on the growing demand for home diagnostic products, which surged during COVID. The retail market for household drug detection kits is estimated to be worth billions annually, positioning IDenta as a significant player. This initiative aims to provide a simple, reliable, and discreet method for consumers to identify substances in various settings, enhancing product accessibility worldwide.
IDenta Corp. (OTCQB: IDTA) released its 2021 second-quarter financial results, showing a 22% decrease in revenue, totaling $387,042 compared to $495,666 in Q2 2020. Despite lower sales, the company achieved a 17% increase in net profit, reaching $112,772. This was attributed to maintaining operational efficiency and adapting quickly to changing market conditions. Gross profit rose by 18% to $286,129, and operating profit also increased by 19% to $119,992. However, cash and cash equivalents fell to $400,704 from $639,705.
IDenta Corp. (OTCQB: IDTA) announced its 2021 Annual Shareholders' meeting scheduled for August 1, 2021, at 8:00 PM (GMT +3) at its Jerusalem headquarters. The company specializes in developing Field Detection and Home Diagnostics Testing Kits for drugs and explosives, as well as unique forensic products for law enforcement and security agencies. CEO Amichai Glattstein expressed excitement about the upcoming meeting and the opportunity to engage with shareholders.
IDenta Corp. (OTCQB: IDTA) has announced its supply of detection field kits to UN Forces in multiple countries for drug presence testing at airports. The company's patented technology is user-friendly and does not require specialized training, making it accessible for various situations. CEO Amichai Glattstein expressed that this partnership with the UN is a significant milestone, enhancing efforts in the global drug war. IDenta's products consistently meet high standards required by law enforcement and security agencies.
IDenta Corp. (OTCQB: IDTA), a leader in detection kits for drugs and explosives, reported a strong first quarter of 2021. Revenue reached $352,247, a 54% increase from $227,571 in Q1 2020. Gross profit rose to $260,739, a 33% increase year-over-year. Although net profit decreased to $69,134 from $72,471, the company maintained profitability while investing $70,000 in equipment. Cash reserves increased 160% to $369,892. CEO Amichai Glattstein emphasized ongoing investments to boost production capacity and expand sales channels.
IDenta Corp. (OTCQB: IDTA) reported a robust performance in its 2020 annual financial statements, revealing a 43% increase in sales revenue, reaching $1,449,899 compared to $1,012,822 in 2019. Gross profit surged by 52.5% to $953,181, while operating profit rose by 345% to $355,573. Notably, net profit soared by 540% to $354,449. CEO Amichai Glattstein emphasized the company's successful strategies and momentum entering 2021, aiming to enhance shareholder value through innovation and product expansion.
IDenta Corp. (OTCQB: IDTA) has announced the provision of its detection field kits to the Federal Police in Brazil. These kits will be utilized for inspecting packages transported by UPS, FedEx, and DHL. The company's patented technology offers a user-friendly, safe, and reliable solution that does not require specialized training. CEO Amichai Glattstein emphasized the significance of this partnership in contributing to global shipment safety and indicated potential growth opportunities for the company. IDenta is recognized for developing advanced testing kits for drugs and explosives in various markets.
IDenta Corp. (OTCQB: IDTA) has successfully completed the testing of its detection kits by the Philippines Drug Enforcement Agency. The agency has initiated the adoption of IDenta's products to enhance the fight against illicit substances in the country. CEO Amichai Glattstein expressed pride in the global adoption of IDenta's reliable and efficient testing products. The Philippines, with a population exceeding 109 million, represents a significant market opportunity for IDenta in Southeast Asia.
IDenta Corp. (OTCQB: IDTA), a leader in drug and explosive detection technologies, played a crucial role in a significant law enforcement operation in Brazil. The company's Field Test Kit helped identify 704 kg of cocaine hidden in a mango fruit container, preventing its export to Europe. CEO Amichai Glattstein highlighted the importance of such technology in enhancing global security. Since 2002, IDenta has developed a range of diagnostic testing kits that meet the stringent requirements of law enforcement agencies worldwide.